15% ịgba ọgwụ Amoxicillin
Ngosipụta
Ọgwụ amoxicillinbụ nkwusioru nke ezigbo ahụ.Mgbe ha guzoro, irighiri ahụ dị mma na-emikpu wee bụrụ nkwusioru na-acha ọcha na-acha ọcha mgbe ha masịrị.Amoxicillin na-egbochi njikọ nke mgbidi cell nke nje bacteria, nke mere na nje bacteria na-eto eto ngwa ngwa ghọọ spheroids na mgbawa na lyse bacteria.Ọ dị mma maka Streptococcus dị iche iche, penicillinase-adịghị emepụta Staphylococcus, Clostridium na nje bacteria ndị ọzọ na-akpata Gram, yana Pasteurella, Mannheimia hemolyticus, Escherichia coli, Salmonella na nje bacteria ndị ọzọ na-adịghị mma.Ọrụ antibacterial.
Mgbe ịgba ọgwụ mgbochi intramuscular na ezì na ehi, bioavailability bụ 60% ruo 100%, na ntinye uche plasma kacha elu nke 1.5 ruo 4.5 µg / ml ruru 1 ruo 3 awa mgbe ịgba ọgwụ mgbochi ahụ gasịrị.Mgbe etinyere ezì na ehi na ngwaahịa a, a na-edobe ntinye ọgwụ ọbara n'elu MIC90 maka awa 36 na awa 72, n'otu n'otu.Mgbe ịgba ọgwụ mgbochi ugboro ugboro (awa 48 n'etiti ntụtụ abụọ), paramita pharmacokinetic kwụsiri ike na enweghị mmetụta mkpokọta.A na-esikarị na akụrụ pụta n'ụdị arụ ọrụ.
Mmekọrịta ọgwụ macrolides, sulfonamides na ọgwụ nje tetracycline na-egbochi njikọ protein nje.Iji ọgwụ nje ndị a n'otu oge nwere ike ibelata mmetụta bactericidal nke amoxicillin.
Ngosipụta: A na-eji ya maka mbufụt nke nje bacteria gram-positive na gram-negative bacteria nke amoxicillin na-enwe mmetụta na ezì na ehi.
Usoro onunu ogwu na nchịkwa
A na-agbakọ ya dị ka amoxicillin.Ngwunye intramuscular: otu dose, 15 mg maka ezi na ehi maka otu kilogram nke ịdị arọ ahụ.Enwere ike ịgba ọgwụ mgbochi ọzọ mgbe awa 48 gachara ma ọ dị mkpa.
Mkpachapụ anya
(1)15% ịgba ọgwụ AmoxicillinA na-egbochi ya na anụmanụ ndị nwere ihe nfụkasị na penicillins.
(2) Ọ bụ contraindicated na emetụta anụmanụ na oké gbasara akụrụ insufficiency.
(3) Gbaa nke ọma tupu eji ya.
(4) Ọ dịghị ihe karịrị 20 ml kwa saịtị ịgba ọgwụ.
Mmeghachi omume ọjọọ
Nlekọta ngwaahịa a nwere ike ibute ihe nfụkasị ahụ, yana mmeghachi ahụ nfụkasị siri ike mgbe ụfọdụ (dịka ujo anaphylactic).
Oge mwepụ
Ụbọchị 16 maka ehi, ụbọchị 20 maka ezi na ụbọchị 3 maka oge abstinence.
Nchekwa
Akara na echekwara na jụụ ebe.
Hebei Veyong Pharmaceutical Co., Ltd, e guzobere na 2002, emi odude ke Shijiazhuang City, Hebei Province, China, na-esote Isi Obodo Beijing.Ọ bụ nnukwu ụlọ ọrụ ọgwụ anụmanụ enwetara ikike nke GMP, yana R&D, mmepụta na ire nke API ọgwụgwọ anụmanụ, nkwadebe, nri agbakwunyere na mgbakwunye nri.Dị ka Provincial Technical Center, Veyong eguzobela usoro R&D ọhụrụ maka ọgwụ anụmanụ ọhụrụ, ma bụrụ ụlọ ọrụ mmepụta ihe ọhụrụ na teknụzụ nke mba ama ama, enwere ndị ọkachamara teknụzụ 65.Veyong nwere abụọ mmepụta bases: Shijiazhuang na Ordos, nke Shijiazhuang isi na-ekpuchi ebe 78,706 m2, na 13 API ngwaahịa gụnyere Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, na 11 nkwadebe mmepụta akara gụnyere injection, oral ngwọta, ntụ ntụ ngwọta. , premix, bolus, pesticides na disinfectant, wdg.Veyong na-enye API, ihe karịrị 100 nkwado akara aha, yana ọrụ OEM & ODM.
Veyong na-etinye aka na njikwa nke sistemụ EHS (Environment, Health & Safety), ma nweta asambodo ISO14001 na OHSAS18001.Edepụtara Veyong n'ime ụlọ ọrụ mmepụta ihe na-emepụta atụmatụ dị na Hebei Province ma nwee ike hụ na ngwaahịa na-aga n'ihu.
Veyong guzobere usoro njikwa mma zuru oke, nweta asambodo ISO9001, asambodo China GMP, asambodo Australia APVMA GMP, asambodo Ethiopia GMP, asambodo Ivermectin CEP, wee gafere nyocha US FDA.Veyong nwere ọkachamara otu ndebanye aha, ahịa na ọrụ teknụzụ, ụlọ ọrụ anyị enwetala ntụkwasị obi na nkwado site n'aka ọtụtụ ndị ahịa site n'ịdị mma ngwaahịa dị mma, ọrụ tupu ire ere na mgbe ire ere, ọrụ siri ike na sayensị.Veyong emewo ogologo okwu imekọ ihe ọnụ na ọtụtụ mba ụwa maara na-emepụta ọgwụ ụlọ ọrụ na ngwaahịa exported na Europe, South America, Middle East, Africa, Asia, wdg karịa 60 mba na mpaghara.